PHILADELPHIA — The Philadelphia Eagles' season has taken a devastating turn. Quarterback Jalen Hurts is likely out for the rest of the 2026 season after doctors discovered blood clots in his lungs, the team and his agent, Nicole Lynn, announced in a joint statement on Monday, 19 October 2026. The updated diagnosis — deep vein thrombosis as well as bilateral pulmonary emboli — is significantly more serious than the superficial blood clot first found in his calf during the team's London trip, and it requires blood thinners that make contact football impossible during treatment. The story is trending per news coverage, with the announcement dominating American sports media on Monday.
The team stressed that the situation, while serious, carries a good outlook. Hurts, 28, is clinically stable, has "no significant functional limitations," and his prognosis is described as "very good," with a full recovery and no long-term effects expected. He is expected to remain active around the team and continue conditioning while he cannot play.
What the diagnosis means
The statement laid out the medical picture in stages. Hurts was initially diagnosed by specialists in London with a superficial vein thrombosis in his left calf — a clot in a vein close to the skin. Superficial clots are less dangerous than deeper ones. But follow-up testing and monitoring in Philadelphia revealed something worse: a deep vein thrombosis, meaning a clot in one of the deep veins of the leg, plus bilateral pulmonary emboli — blood clots in both lungs.
A pulmonary embolism occurs when a clot travels from a deep vein — most often in the leg — and lodges in an artery of the lung, blocking blood flow. "Bilateral" means both lungs are affected. Symptoms can include shortness of breath, chest pain, fainting, rapid heartbeat and leg swelling. According to the Mayo Clinic's definitions cited by USA Today, deep vein thrombosis forms in the deep veins of the body, usually the legs, and a pulmonary embolism blocks blood flow to an artery in the lung — making the combination the most feared form of venous thromboembolism.
Treatment is expected to involve only anticoagulation — blood thinners — but blood thinners and contact sports are an impossible combination: they sharply increase bleeding risk from hits, so Hurts "will not be allowed to participate in any contact activities, including football" during treatment. In professional sports, the protocol is rigid — players are rarely cleared for contact until imaging confirms the clots have fully resolved, which typically takes months. Former Miami Dolphins linebacker Jerome Baker was sidelined for half a season in 2022 under similar circumstances.
How we got here: a timeline
The ordeal began in London. An initial ultrasound on 10 October, when the Eagles arrived in London, revealed the calf clot. Hurts nonetheless played in the 19-17 loss to the Jacksonville Jaguars on 11 October — a remarkable effort, given the circumstances. ESPN reported he had been in the hospital until 4 a.m. the night before the game, and doctors had told him not to sleep as a precaution; NFL insider Tom Pelissero reported he had been awake for roughly 36 hours when he started, yet still threw for 220 yards and a touchdown, nearly leading Philadelphia to an upset without Saquon Barkley and DeVonta Smith.
A follow-up ultrasound in Philadelphia showed the clot had moved, and further testing uncovered the lung clots. The Eagles announced last Thursday (15 October) that Hurts would miss the Week 6 game against the Carolina Panthers, then placed him on injured reserve on Saturday, and Monday's statement delivered the season-ending verdict. The New York Post reported he will be out for roughly three months, into mid-January, while other reports stopped short of a formal timeline — treatment, not the calendar, will decide.
A franchise quarterback sidelined
Hurts is not just a starter; he is the face of the franchise and the MVP of Super Bowl LIX. A three-time Pro Bowl selection, he has compiled a 59-28 regular-season record since taking over as starter late in his rookie season in 2020, passing for 18,824 yards with 118 touchdowns and 48 interceptions, plus 3,661 rushing yards and 64 rushing touchdowns — one of the most productive dual-threat careers in league history. Through five starts this season he completed 57.8% of his passes for 933 yards, eight touchdowns and three interceptions, with a 2-3 record.
His absence lands at the worst possible moment. The Eagles are 2-4 and riding a four-game losing streak after Sunday's 25-14 home loss to the Panthers, in which Philadelphia gained just 222 total yards and 35 rushing yards. Left tackle Jordan Mailata publicly faulted the team's focus, and the offense has averaged just 14 points over the past month. The betting markets have reacted brutally: the Eagles have dropped from +4000 to +15000 to win the Super Bowl in two weeks, and sit at +460 to make the playoffs, per Sports Illustrated. ESPN analyst Stephen A. Smith declared on air, "The Eagles are done."
Tanner McKee inherits the offense
The season now rests on 26-year-old Tanner McKee, the Stanford product who was Philadelphia's third-stringer just weeks ago. McKee was drafted in the sixth round in 2023 and had barely played before this season: prior to 2026 he had appeared in six games with two starts, both on the final day of seasons with backups playing. He opened this season behind Hurts and veteran Andy Dalton, was promoted to No. 2 after Dalton's disastrous one-pass debut, and Dalton was released last Friday.
McKee's first meaningful start came Sunday against Carolina: 26 of 45 for 215 yards, one touchdown, three sacks in the 25-14 loss. He was brutally honest about his own performance afterward and said the team needs him to improve. His next test comes quickly — next Monday night against the Dallas Cowboys, who also sit at 2-4 with collapsing postseason hopes of their own. Behind McKee, the Eagles have rookie fifth-round pick Cole Payton and Joe Milton, signed off the Cowboys' practice squad on Friday.
The bigger question may be the trade market. With the 10 November deadline approaching and Hurts gone for the year, general manager Howie Roseman must decide whether to acquire a veteran starter or let McKee try to save a spiraling season. It is a brutal calculus for a team that won the Super Bowl less than two years ago — echoing other shocking NFL seasons derailed by injury, including the Cardinals' stunning upset of the Rams this weekend, which became the league's biggest upset of the 2026 season.
The bigger picture
For all the football implications, Monday's statement kept the emphasis where it belongs: on Hurts' health. Blood clots in the lungs are a genuinely dangerous condition, and the team's transparency — unusual for injury reporting — reflected the gravity. The encouraging news is the medical consensus behind the "very good" prognosis: with anticoagulation treatment, deep vein thrombosis and pulmonary emboli are highly treatable, and Hurts is expected to return to contact football once he is off blood thinners, with no long-term effects anticipated.
Hurts' season ends at 933 passing yards and eight touchdowns across five starts — his last appearance the London loss to Jacksonville. His final line of the season is far less important than his final line in the statement: he will remain active around the team, continue to condition, and the team expects him back. For Philadelphia, the 2026 season becomes a survival exercise; for its quarterback, it becomes a recovery story — and, if the doctors are right, only a one-season detour in a career still near its peak.
Sources: Reuters via Field Level Media (19 October 2026); NBC Sports Philadelphia / Dave Zangaro (19 October 2026); USA Today (19 October 2026); New York Post (19 October 2026); Sports Illustrated betting desk (19 October 2026); Athlon Sports (19 October 2026); statement from Philadelphia Eagles and agent Nicole Lynn (19 October 2026); Google Trends 'Trending now' (19 October 2026).